Valyu vs Exa Comparison
| Feature | Valyu | Exa |
|---|---|---|
| Semantic Search | Yes | Yes |
| Web Search | Yes | Yes |
| Proprietary Data Sources | 36+ sources | Limited |
| Academic Papers | PubMed, arXiv, bioRxiv (40M+ papers) | Limited |
| SEC Filings | 3M+ filings with full-text search | No |
| Clinical Trials | 500K+ trials from ClinicalTrials.gov | No |
| Financial Data | Real-time stocks, crypto, forex | No |
| Drug Databases | ChEMBL, DrugBank, FDA labels | No |
| Patent Search | 8M+ US patents | No |
| Economic Data | FRED, BLS, World Bank | No |
Why Teams Switch to Valyu
1. Proprietary Data Access
Exa excels at neural search over the web. Valyu adds access to data sources that aren’t publicly indexed:- 37M+ PubMed papers - Full-text biomedical literature
- 3M+ SEC filings - Corporate disclosures with semantic search
- 500K+ clinical trials - Study protocols and outcomes
- 2.5M+ ChEMBL molecules - Drug discovery data
- 8M+ patents - IP and prior art search
2. Better for Specialized Domains
For AI agents in finance, healthcare, or research, you need more than web search:3. Structured Data Support
Valyu returns structured data alongside unstructured content:When to Choose Valyu Over Exa
Choose Valyu if you need:- Domain-specific data - Healthcare, finance, academic, patents
- Proprietary sources - Data behind paywalls and APIs
- Structured data - Financial metrics, clinical trial data, drug properties
- Full-text academic search - Beyond abstracts into paper content
- Deep research - Multi-step research with comprehensive reports
- Neural search over publicly available web content
Code Comparison
Benchmark Performance
Valyu outperforms alternatives on domain-specific benchmarks:| Benchmark | Valyu | Exa | |
|---|---|---|---|
| FreshQA (time-sensitive) | 79% | 24% | 39% |
| SimpleQA (factual) | 94% | 91% | 38% |
| Finance | 73% | 63% | 55% |
| MedAgent (medical) | 48% | 44% | 45% |
Get Started
Get Started Free
Sign up and get $10 in free credits. No credit card required.

